Patents Assigned to SYMYTHERA CANADA LTD.
  • Patent number: 11207381
    Abstract: The invention provides a pharmaceutical composition including a peptide comprising at least a portion of a chemokine receptor or a G-protein coupled receptor and optionally a cytokine. The pharmaceutical composition of the invention may be used for altering immune system functioning, for example, to treat an immune system disorder, such as an autoimmune disease, multiple sclerosis, transplant rejection, psoriasis and asthma. The invention also provides peptides that may be used in the pharmaceutical composition and a method for preparing the pharmaceutical composition of the invention. The invention further provides a method for to treating an immune system disorder, such as an autoimmune disease, multiple sclerosis, transplant rejection, and psoriasis asthma.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: December 28, 2021
    Assignee: SYMYTHERA CANADA LTD.
    Inventors: Chai Ezerzer, Nicholas Harris